Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Hank, Nicole C ^a   Shapiro, Joan Rankin ^a   Scheck, Adrienne C ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; ALKYLATING AGENT;

ADULT; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL SELECTION; CELL SURVIVAL; CHROMOSOME 22; CHROMOSOME 22Q; CHROMOSOME 7; CHROMOSOME MAP; CHROMOSOME MARKER; CONTROLLED STUDY; DIPLOIDY; DNA SEQUENCE; DRUG RESISTANCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE PROBE; GENETIC ANALYSIS; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPING; MALE; TUMOR RECURRENCE; BRAIN TUMOR; GENETICS; GLIOMA; MIDDLE AGED; TUMOR CELL CULTURE;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; CELL SURVIVAL; CHROMOSOMES, HUMAN, PAIR 22; DRUG RESISTANCE, NEOPLASM; FEMALE; GLIOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; TUMOR CELLS, CULTURED;

EID: 30644479193     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-2     Document Type: Article

References (21)

1. Shapiro WR, Shapiro JR, Walker RW: Central Nervous System. In Clinical Oncology. Edited by Edited by Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. New York: Churchill Livingstone; 1995:851-912.
2. Shapiro JR: Cellular characterization and BCNU resistance of freshly resected and early passage human glioma cells. Progress in Neuropathology 1986, 6:133-143.
3. Watkins D, Ruttledge MH, Sarrazin J, Rangaratnam S, Poisson M, Delattre JY, Rouleau GA: Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene. Cancer Genet Cytogenet 1996, 92:73-78.
4. Weremowicz S, Kupsky WJ, Morton CC, Fletcher JA: Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet Cytogenet 1992, 61:193-196.
5. Arslantas A, Artan S, Oner U, Muslumanoglu H, Durmaz R, Cosan E, Atasoy MA,Basaran N, Tel E: The importance of genomic copy number changes in the prognosis of glioblastoma multiforme. Neurosurg Rev 2004, 27:58-64.
6. Lang FF, Miller DC, Koslow M, Newcomb EW: Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994, 81:427-436.
7. Schlegel J, Scherthan H, Arens N, Stumm G, Kiessling M: Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization. J Neuropath Exper Neurol 1996, 55:81-87.
8. Scheck AC, Mehta BM, Beikman MK, Shapiro JR: BCNU-resistant human glioma cells with over-representation of chromosomes 7 and 22 demonstrate increased copy number and expression of platelet-derived growth factor genes. Genes, Chromosomes & Cancer 1993, 8:137-148.
9. Scheck AC, Shapiro JR, Ballacer C, Kohlke E, Rhodes SN, Sinnott HA, Norman SA, Bohnert A: Clonal analysis of human malignant glioma cells selected for resistance to BCNU [abstract]. Proceedings of the American Association for Cancer Research 1996, 37:338
10. Scheck AC, Mehta BM, Beikman MK, Shapiro JR: BCNU-resistant human glioma cells with over-representation of chromosomes 7 and 22 demonstrate increased copy number and expression of platelet-derived growth factor genes. Genes, Chromosomes & Cancer 1993, 8:137-148.
11. Asch AS, Leung LLK, Shapiro JR, Nachman RL: Human brain glial cells synthesize thrombospondin. Proc Natl Acad Sci USA 1986, 83:2904-2908.
12. Norman SA, Rhodes SN, Treasurywala S, Hoelzinger DB, Shapiro JR, Scheck AC: Identification of transforming growth factor-beta1 binding protein over-expression in BCNU-resistant glioma cells by differential mRNA display. Cancer 2000, 89:850-862.
13. Shapiro JR, Yung W-KA, Shapiro WR: Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res 1981, 41:2349-2359.
14. Bangs CD, Donlon TA: Cytogenetics. In Current Protocols in Human Genetics. Edited by Edited by Dracopoli NC, Haines JL, Korf BR, Moir DT, Morton CC, Seidman JG, Smith DR. New York: John Wiley & Sons; 2000:4.14.12.7.
15. An International System for Human Cytogenetic Nomenclature. Basel: Published in collaboration with Cytogenet Cell Genet. (Suppl), Karger; 1985.
16. Guidelines for cancer cytogenetics. Supplement to an international system for human genetic nomenclature. New York: S. Karger; 1991.
17. Dunham I, Dewar K, Kim U-J, Ross MT: Bacterial Cloning Systems. In Volume 3/Cloning Systems. Volume 3. Edited by Edited by Birren B, Green ED, Klapholz S, Myers RM, Riethman H, Roskams J. Plainview, N.Y.: Cold Spring Harbor Laboratory Press; 1999:1-87.
18. Shapiro JR, Scheck AC: Brain tumors. In Cytogenetic markers of human cancer. Edited by Edited by Wolman SR, Sell S. New Jersey: The Humana Press, Inc.; 1997:319-368.
19. Claesson-Welsh L, Eriksson A, Morën A, Severinsson L, Ek B, Ostman A, Betsholtz C, Heldin CH: cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cell Biol 1988, 8:3476-3486.
20. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ: RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
21. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V: Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 2004, 5:R13.